has been cited by the following articles in journals that are participating in CrossRef's forward linking service: |
||
| Rhodanine Derivatives as Selective Protease Inhibitors Against Bacterial Toxins Sherida L. Johnson, Li-Hsing Chen, Rebecca Harbach, Mojgan Sabet, Alexei Savinov, Naomi J. H. Cotton, Alex Strongin, Donald Guiney, and Maurizio Pellecchia Chemical Biology & Drug Design (2008) 71: 131 Link to Article |
||
| The Design of Inhibitors for Medicinally Relevant Metalloproteins Faith E. Jacobsen, Jana A. Lewis, and Seth M. Cohen ChemMedChem (2007) 2: 152 Link to Article |
||
| New insights into the pathogenesis and treatment of anthrax toxin-induced shock Yan Li, Kevin Sherer, Xizhong Cui, and Peter Q Eichacker Expert Opinion on Biological Therapy (2007) 7: 843 Link to Article |
||
| Structural biology approaches to antibacterial drug discovery Tod P Holler, Artem G Evdokimov, and Lakshmi Narasimhan Expert Opinion on Drug Discovery (2007) 2: 1085 Link to Article |
||
| Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism Dimitrios G Bouzianas Expert Review of Anti-infective Therapy (2007) 5: 665 Link to Article |
||
| A decade of fragment-based drug design: strategic advances and lessons learned Philip J. Hajduk and Jonathan Greer Nature Reviews Drug Discovery (2007) 6: 211 Link to Article |
||
| Evaluation and Binding-Mode Prediction of Thiopyrone-Based Inhibitors of Anthrax Lethal Factor Jana A. Lewis, John Mongan, J. Andrew McCammon, and Seth M. Cohen ChemMedChem (2006) 1: 694 Link to Article |
||